Cargando…

Inducible and reversible RNA N(6)-methyladenosine editing

RNA modifications, including N(6)-methyladenosine (m(6)A), have been reported to regulate fundamental RNA processes and properties, and directly linked to various human diseases. Methods enabling temporal and transcript/locus-specific editing of specific RNA modifications are essential, but still li...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Huaxia, Xu, Ying, Tian, Na, Yang, Ming, Liang, Fu-Sen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005610/ https://www.ncbi.nlm.nih.gov/pubmed/35414049 http://dx.doi.org/10.1038/s41467-022-29665-y

Ejemplares similares

On demand CRISPR-mediated RNA N6-methyladenosine editing
por: Xu, Ying, et al.
Publicado: (2022)

Programmable RNA N(6)-methyladenosine editing by CRISPR-Cas9 conjugates
por: Liu, Xiao-Min, et al.
Publicado: (2019)

Function and evolution of RNA N6-methyladenosine modification
por: Zhu, Zhi-Man, et al.
Publicado: (2020)

The roles of RNA N(6)-methyladenosine in esophageal cancer
por: Teng, Chuan, et al.
Publicado: (2022)

Epitranscriptomic editing of the RNA N6-methyladenosine modification by dCasRx conjugated methyltransferase and demethylase
por: Xia, Zhen, et al.
Publicado: (2021)

The Potential Roles of RNA N6-Methyladenosine in Urological Tumors
por: Li, Yang, et al.
Publicado: (2020)

circRNA N6-methyladenosine methylation in preeclampsia and the potential role of N6-methyladenosine-modified circPAPPA2 in trophoblast invasion
por: Zhang, Yonggang, et al.
Publicado: (2021)

RNA N(6)-Methyladenosine Modifications and the Immune Response
por: Wang, Ya-Nan, et al.
Publicado: (2020)

Role of Main RNA Methylation in Hepatocellular Carcinoma: N6-Methyladenosine, 5-Methylcytosine, and N1-Methyladenosine
por: Xu, Yating, et al.
Publicado: (2021)

Reversible N6-methyladenosine of RNA: The regulatory mechanisms on gene expression and implications in physiology and pathology
por: Fang, Xinyu, et al.
Publicado: (2020)

Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase
por: Ping, Xiao-Li, et al.
Publicado: (2014)

N(6)-Methyladenosine in Nuclear RNA is a Major Substrate of the Obesity-Associated FTO
por: Jia, Guifang, et al.
Publicado: (2011)

The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer
por: Hu, Xiaoge, et al.
Publicado: (2022)

RNA N(6)-methyladenosine modulates endothelial atherogenic responses to disturbed flow in mice
por: Li, Bochuan, et al.
Publicado: (2022)

N(6)‐methyladenosine (m(6)A) RNA modification in human cancer
por: Huo, Fu‐Chun, et al.
Publicado: (2020)

Overview of distinct N6-Methyladenosine profiles of messenger RNA in osteoarthritis
por: Yu, Yang, et al.
Publicado: (2023)

The Epigenetic Regulation of RNA N6-Methyladenosine Methylation in Glycolipid Metabolism
por: Yang, Haiqing, et al.
Publicado: (2023)

The role of RNA N(6)-methyladenosine methyltransferase in cancers
por: Huang, Jiali, et al.
Publicado: (2021)

N6-Methyladenosine RNA Methylation in Cardiovascular Diseases
por: Liu, Chi, et al.
Publicado: (2022)

Main N6-Methyladenosine Readers: YTH Family Proteins in Cancers
por: Dai, Xin-Yuan, et al.
Publicado: (2021)

Mechanism of RNA modification N6-methyladenosine in human cancer
por: Zhou, Zijian, et al.
Publicado: (2020)

The emerging roles of N6-methyladenosine RNA modifications in thyroid cancer
por: Xu, Xiaoxin, et al.
Publicado: (2023)

Alteration of N6-Methyladenosine RNA Profiles in Cisplatin-Induced Acute Kidney Injury in Mice
por: Li, Can-Ming, et al.
Publicado: (2021)

N(6)-methyladenosine regulates RNA abundance of SARS-CoV-2
por: Zhang, Ting, et al.
Publicado: (2021)

Epigenetic N6-methyladenosine modification of RNA and DNA regulates cancer
por: Liang, Zhixian, et al.
Publicado: (2020)

Detection of N(6)-methyladenosine modification residues (Review)
por: Zhu, Wei, et al.
Publicado: (2019)

The emerging roles of N6-methyladenosine RNA methylation in human cancers
por: Shen, Huafei, et al.
Publicado: (2020)

Immunological characterization and diagnostic models of RNA N6-methyladenosine regulators in Alzheimer's disease
por: Hui, Yuan, et al.
Publicado: (2023)

METTL3-mediated mRNA N(6)-methyladenosine is required for oocyte and follicle development in mice
por: Mu, Haiyuan, et al.
Publicado: (2021)

The Roles of RNA N6-Methyladenosine in Regulating Stem Cell Fate
por: Ji, Runbi, et al.
Publicado: (2021)

N6-methyladenosine methylation in kidney injury
por: Wang, Qimeng, et al.
Publicado: (2023)

N6-Methyladenosine RNA Modification in Inflammation: Roles, Mechanisms, and Applications
por: Luo, Jiahui, et al.
Publicado: (2021)

RNA N6-Methyladenosine Responds to Low-Temperature Stress in Tomato Anthers
por: Yang, Dandan, et al.
Publicado: (2021)

The Role of N(6)-Methyladenosine in Inflammatory Diseases
por: Xu, Haojun, et al.
Publicado: (2022)

Roles of N(6)‐methyladenosine (m(6)A) RNA modifications in urological cancers
por: Wang, Xiao, et al.
Publicado: (2020)

Modification of N(6)-methyladenosine RNA methylation on heat shock protein expression
por: Yu, Jiayao, et al.
Publicado: (2018)

The reverse transcription signature of N-1-methyladenosine in RNA-Seq is sequence dependent
por: Hauenschild, Ralf, et al.
Publicado: (2015)

The RNA N6-Methyladenosine Methyltransferase METTL3 Promotes the Progression of Kidney Cancer via N6-Methyladenosine-Dependent Translational Enhancement of ABCD1
por: Shi, Yue, et al.
Publicado: (2021)

The Roles of N(6)-Methyladenosine in Human Diseases
por: An, Shanshan, et al.
Publicado: (2019)

Functional Implications of Active N(6)-Methyladenosine in Plants
por: Zheng, Hongxiang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dt9vmhaptrrue533ms8rd3meot